Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Factor XII inhibitors for the treatment of neurological inflammatory disorders

Factor XII inhibitors for the treatment of neurological inflammatory disorders

US Patent 9957329 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy using a factor XII inhibitor in a neurotraumatic disorder2024
Therapy using a factor XII inhibitor in a neurotraumatic disorder2024
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidne2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies2022
Treatment and prevention of remote ischemia-reperfusion injury2021
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies2019
Treatment and prevention of remote ischemia-reperfusion injury2019
Detection of anti-neurochondrin autoantibody in patients with cerebellar ataxia 2018
Factor XII inhibitors for the administration with medical procedures comprising 2018
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies2018
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies2018
Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of2017